The city of Dallas, Texas, currently has 2 active clinical trials seeking participants for Hepatitis C research studies.
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
Recruiting
To acquire blood samples from subjects for various purposes, including: i) determining the sensitivity and specificity of select DNA methylation markers for the detection of various types of cancer, ii) identifying benign conditions that may induce false positive or false negative results, and iii) defining the effects of potential interfering substances, such as chemotherapy drugs.
Gender:
All
Ages:
18 years and above
Trial Updated:
07/10/2023
Locations: Liver Center of Texas, Dallas, Texas
Conditions: Cancer, Liver Cirrhosis, Chronic Hepatitis, Hepatitis B, Hepatitis C, Diabetes, COPD
The Hepatitis C Transplant Collaborative
Recruiting
In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/25/2023
Locations: Baylor Scott & White Health Research Institute, Dallas, Texas
Conditions: Transplant; Failure, Heart, Hepatitis C